← Leaderboards
Jiri Zemlicka
University Of Michigan At Ann Arbor
$2,189,947
Attributed
$2,189,947
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $203.8K · FY2005–08$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,189,947 · 2
By mechanism
R01$1,688,357 · 1
P01$501,590 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Carol A Fierke$10,633,810
- Paul H Krebsbach$14,552,783
- Cornelius J McGinn$909,301
Others in their field
Top investigators on “Antiviral Agents”
- Constance Ann Benson · University Of California, San Diego$209,152,068
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$120,325,769
- Judith S. Currier · University Of California Los Angeles$102,391,456
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Sharon A Nachman · Johns Hopkins University$77,262,665
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,660,403
Research focus
Antiviral AgentsCytomegalovirusDrug Design /Synthesis /ProductionProdrugsNucleoside AnalogHuman Immunodeficiency VirusCyclopropanesAntineoplasticsHerpes Simplex Virus 1StereoisomerNeoplasm /CancerThiophosphateAminopurineChemical Registry /ResourceNucleosidesNucleotide AnalogPhosphonateSeriesStructureStructure-Activity RelationshipViralAnalogAntitumor AgentAntiviral Nucleoside Analog
Grant awards (12)
Antitumor and Antiviral Nucleoside Analogues$193,288
R01 · FY2008 · CA · contact PI
Antitumor and Antiviral Nucleoside Analogues$193,288
R01 · FY2007 · CA · contact PI
Antitumor and Antiviral Nucleoside Analogues$199,060
R01 · FY2006 · CA · contact PI
Antitumor and Antiviral Nucleoside Analogues$203,850
R01 · FY2005 · CA
Antitumor and Antiviral Nucleoside Analogues$186,250
R01 · FY2004 · CA
Antitumor and Antiviral Nucleoside Analogues$186,250
R01 · FY2003 · CA
Antitumor and Antiviral Nucleoside Analogues$216,344
R01 · FY2002 · CA
METHYLENECYCLOPROPANE ANALOGS AND PRODRUGS FOR HCMV$157,141
P01 · FY2002 · AI
ANTITUMOR AND ANTIVIRAL NUCLEOSIDE ANALOGUES$157,305
R01 · FY2001 · CA
METHYLENECYCLOPROPANE ANALOGS AND PRODRUGS FOR HCMV$157,141
P01 · FY2001 · AI
METHYLENECYCLOPROPANE ANALOGS AND PRODRUGS FOR HCMV$187,308
P01 · FY2000 · AI
ANTITUMOR AND ANTIVIRAL NUCLEOSIDE ANALOGUES$152,722
R01 · FY2000 · CA